Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ENDRA Life Sciences Inc
NDRA | US
3.43
USD-0.21
-5.77%
NDRA | US
About ENDRA Life Sciences Inc
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
05/03/2026
Close
3.43
Open
3.56
High
3.63
Low
3.40
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves which bounce off tissues organs and blood in the body for use in the treatment of nonalcoholic fatty liver disease as well as in tissue composition temperature monitoring vascular imaging and tissue perfusion. It also offers diagnostic imaging technologies such as computed tomography magnetic resonance imaging and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions such as broken bones cancers signs of heart disease or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor Michigan.
View LessNDRA | US
Risk
68.1
Sharpe
-0.10
Luna's Score
45/100
Recommendation
Sell
Luna says (NDRA | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
87.6%1 month
68.1%3 months
75.1%6 months
103.5%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.41
Debt to equity
0.03
Debt to assets
0.03
Ent. to EBITDA
-0.11
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-9.52M
MarketCap
63.08M
MarketCap(USD)
63.08M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-120.13
Short ratio
0.13
Short perc.
1.48
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
2.57
Range1M
2.69
Range3M
2.85
Volumes: Market Activity
Rel. volume
0.04
Price X volume
32.98K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.11 | 12.67 | Cheaper |
| Ent. to Revenue | - | 44.00 | - |
| PE Ratio | - | 40.09 | - |
| Price to Book | 0.41 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 75.11 | 59.59 | Riskier |
| Debt to Equity | 0.03 | -14.36 | Expensive |
| Debt to Assets | 0.03 | 0.34 | Cheaper |
| Market Cap | 63.08M | 13.71B | Emerging |
